Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 19, 2018

Study Completion Date

July 19, 2018

Conditions

Cocaine Use Disorder

Interventions

DRUG

Lorcaserin

Lorcaserin HCL 10mg tablets (Belviq, Arena Pharmaceuticals)

DRUG

Cocaine Intravenous (IV)

Cocaine IV administered at doses of 10, 20 and 40 mg during 4 dosing sessions

DRUG

Placebo comparator

Dextrose in gelatin capsule

Trial Locations (1)

Virginia Commonwealth University, Institute for Drug and Alcohol Studies, Richmond

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Virginia Commonwealth University

OTHER

NCT02537873 - Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder | Biotech Hunter | Biotech Hunter